Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-06-16

Clinical Trial Update: Effect of Berberine for Endothelial Function and Intestinal Microflora in Patients With Coronary Artery Disease [Phase 1, Phase 2]

View source ↗

Summary

An early-stage clinical trial investigating berberine for endothelial function and intestinal microflora in patients with coronary artery disease, spanning Phas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Berberine (berberine)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Stable Coronary Artery Disease, Percutaneous Coronary Intervention | Phase 1, Phase 2 | Status: UNKNOWN